| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2146290 | Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis | 2014 | 10 Pages |
•15-Deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2) induces expression of 15-PGDH in MDA-MB-231 cells.•15-PGJ2 induced phosphorylation of Elk-1, one of Ets transcription factor family members.•Induction of 15-PGDH by 15d-PGJ2 is associated with ROS-mediated activation of ERK1/2 and subsequently Elk-1.•15d-PGJ2 inhibited the migration of MDA-MB-231 cells, which was associated with induction of 15-PGDH in breast cancer cells.
Overproduction of prostaglandin E2 (PGE2) has been reported to be implicated in carcinogenesis. The intracellular level of PGE2 is maintained not only by its biosynthesis, but also by inactivation/degradation. 15-Hydroxyprostaglandin dehydrogenase (15-PGDH) is the key enzyme that catalyzes the conversion of oncogenic PGE2 to a biologically inactive keto metabolite. In the present study, we demonstrate that 15-deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2), one of the terminal products of cyclooxygenase-2, updregulates the expression and the activity of 15-PGDH in human breast cancer MDA-MB-231 cells. By using deletion constructs of the 15-PGDH promoter, we have found that E-twenty six (Ets) is the most essential determinant for 15-PGDH induction. 15d-PGJ2 induced phosphorylation of Elk-1, one of Ets transcription factor family members, in the nucleus. Knockdown of Elk-1 abolished the ability of 15d-PGJ2 to upregulate 15-PGDH expression. Furthermore, 15d-PGJ2-mediated activation of Elk-1 was found to be dependent on activation of extracellular-signal related kinase (ERK) 1/2. Treatment of U0126, a pharmacological inhibitor of MEK1/2-ERK, abolished phosphorylation and DNA binding of Elk-1 as well as 15-PGDH induction in 15d-PGJ2-treated MDA-MB-231 cells. Moreover, 15d-PGJ2 generated reactive oxygen species (ROS), which contribute to the expression of 15-PGDH as well as phosphorylation of ERK1/2 and Elk-1. 15d-PGJ2 inhibited the migration of MDA-MB-231 cells, which was attenuated by transient transfection with 15-PGDH siRNA. Taken together, these findings suggest that 15d-PGJ2 induces the expression of 15-PGDH through ROS-mediated activation of ERK1/2 and subsequently Elk-1 in the MDA-MB-231 cells, which may contribute to tumor suppressive activity of this cyclopentenone prostaglandin.
